196 related articles for article (PubMed ID: 7106166)
1. Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.
Brantmark B; Wåhlin-Boll E; Melander A
Eur J Clin Pharmacol; 1982; 22(4):309-14. PubMed ID: 7106166
[TBL] [Abstract][Full Text] [Related]
2. Systemic availability of acetylsalicylic acid in human subjects after oral ingestion of three different formulations.
Petersen T; Husted SE; Pedersen AK; Geday E
Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):285-91. PubMed ID: 7180498
[TBL] [Abstract][Full Text] [Related]
3. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
Montgomery PR; Sitar DS
Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies.
Roberts MS; McLeod LJ; Cossum PA; Vial JH
Eur J Clin Pharmacol; 1984; 27(1):67-74. PubMed ID: 6436031
[TBL] [Abstract][Full Text] [Related]
5. Plasma salicylate levels and platelet function after acute and chronic administration of slow-release acetylsalicylic acid (Monobeltin).
Rehders K; Simrock R; Spahn H; Mutschler E; Breddin HK
Eur J Clin Pharmacol; 1985; 27(6):683-7. PubMed ID: 3987774
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function.
Ross-Lee LM; Elms MJ; Cham BE; Bochner F; Bunce IH; Eadie MJ
Eur J Clin Pharmacol; 1982; 23(6):545-51. PubMed ID: 7160424
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction of acetylsalicylic acid and dipyridamole.
Nitelius E; Melander A; Wåhlin-Boll E
Br J Clin Pharmacol; 1985 Mar; 19(3):379-83. PubMed ID: 3986089
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
Patrick J; Dillaha L; Armas D; Sessa WC
Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
Caplain H
Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
[TBL] [Abstract][Full Text] [Related]
10. Gastric emptying and absorption of acetylsalicylic acid administered as enteric-coated micro-granules.
Alpsten M; Bogentoft C; Ekenved G; Sölvell L
Eur J Clin Pharmacol; 1982; 22(1):57-61. PubMed ID: 7094976
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of salicylic acid and acetylsalicylic acid in aspirin delayed-release tablet formulations by second-derivative UV spectrophotometry.
Kokot Z; Burda K
J Pharm Biomed Anal; 1998 Dec; 18(4-5):871-5. PubMed ID: 9919990
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two enteric-coated acetylsalicylic acid preparations by monitoring steady-state levels of salicylic acid and its metabolites in plasma and urine.
Edgar B; Bogentoft C; Lagerström PO
Biopharm Drug Dispos; 1984; 5(3):251-60. PubMed ID: 6541512
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic Study of Enteric-Coated Sustained-Release Aspirin Tablets in Healthy Chinese Participants.
Cong D; Qi W; Liu X; Xu X; Dong L; Xue W; Li K
Drug Des Devel Ther; 2023; 17():2421-2429. PubMed ID: 37614377
[TBL] [Abstract][Full Text] [Related]
14. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma".
Cerletti C; Latini R; Del Maschio A; Galletti F; Dejana E; de Gaetano G
Thromb Haemost; 1985 Jun; 53(3):415-8. PubMed ID: 4049312
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation and plasma levels of acetylsalicylic acid in stroke patients on long-term treatment with an enteric-coated aspirin formulation.
Britton M; Melander A; Svensson J; Wåhlin-Boll E
Eur J Clin Pharmacol; 1984; 27(3):363-5. PubMed ID: 6510466
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet.
Lücker PW; Wetzelsberger N; Schettler T; Rogalla K
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):805-11. PubMed ID: 1297896
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of two formulations of acetylsalicylic acid gums.
Bousquet E; Tirendi S; Bonina FP; Montenegro L; Bianchi A; Ciampini N
Pharmazie; 1992 Aug; 47(8):607-9. PubMed ID: 1438512
[TBL] [Abstract][Full Text] [Related]
18. Placental drug transfer in near-term ewes: acetylsalicylic and salicylic acid.
Thiessen JJ; Salama RB; Coceani F; Olley PM
Can J Physiol Pharmacol; 1984 Apr; 62(4):441-5. PubMed ID: 6733590
[TBL] [Abstract][Full Text] [Related]
19. Actions and interactions of acetylsalicylic acid, salicylic acid and diflunisal on platelet aggregation.
Nitelius E; Brantmark B; Fredholm B; Hedner U; Forshell GP; Wåhlin-Boll E; Melander A
Eur J Clin Pharmacol; 1984; 27(2):165-8. PubMed ID: 6499897
[TBL] [Abstract][Full Text] [Related]
20. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
